News

Kim Kjøller, MD, breaks down the findings from ECZTRA1, 2, and 3.

New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.

The approval are based on a pair of recent phase 3 trials showing the safety and efficacy of budesonide/glycopyrrolate/formoterol fumarate.

Kim Kjøller, MD, discusses how tralokinumab can be used for the treatment of atopic dermatitis.

More than 40% of critically ill patients died within 90 days regardless of timing of renal-replacement therapy.

Until more is known about long-term cardiac mechanisms behind MIS-C, providers could consider following Kawasaki disease guidelines for follow-up care

Patients in the DBT group were less likely to drop out early and had higher rates of symptomatic remission than a comparison CPT treatment group.

How a decades-long issue has resulted in at-need patients lacking confident, available physicians.

Although nature is beneficial, other social determinants of health might need to be addressed more imminently.

It has been notoriously difficult to measure sensitization to the alpha-Gal carbohydrate.

Canagliflozin is a known treatment for kidney disease, as well as heart failure in patients with type 2 diabetes and diabetic nephropathy.

The ongoing COVID-19 pandemic has forced several ophthalmologists to cancel appointments with patients who might be at a risk of developing sight-threatening illnesses.

The findings provide data to help physicians, patients, and caregivers make informed, shared decisions on the management of peanut allergy.

Patients face higher mortality risk if they are readmitted to a different hospital following emergency general surgery.

The approval represents the second approved treatment of the conditions associated with narcolepsy patients at least 7 years old.

An expert explains why little progress has been made in disease prevalence and burden in the US.

An expert discusses nature counseling, how to prescribe it, and who might benefit from it.

The association of DAA treatment with mortality did not differ by sex in the cirrhosis group.

Symptom provocation did not meaningfully alter the diagnostic sensitivity and specificity that is relative to more easily obtained pretests symptom ratings.

Both telemedicine and face-to-face therapy resulted in improved daytime function.

Women who have recurrent infections have fewer types of bacteria in their urine than those who do not have infections.

The risk of reoffended is lower in males with 5 or more clinical contacts.

The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.

Cataracts and diabetic retinopathy are the 2 leading causes of acquired blindness worldwide.

A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.

There is a growing amount of literature showing the physical, mental, and social benefits of nature.

New scoring model is based on an eight-point threshold to accurately predict patients at a low risk of adverse outcomes.

AI can help make up for missed appointments and screening.